Neurogene (NGNE) Debt Ratio (2013)

Neurogene (NGNE) posted Debt Ratio of 0.15 for Q4 2013.

Neurogene (NGNE) Debt Ratio (2013) Analysis & Trends

Neurogene's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.15 for Q4 2013.

Quarterly Debt Ratio changed N/A year-over-year to 0.15 in Q4 2013, while the trailing twelve-month figure through Dec 2013 was 0.15 (changed N/A YoY) and the FY2013 annual result came in at 0.15, changed N/A from the prior year.
Debt Ratio was 0.15 for Q4 2013 at Neurogene.
Across five years, Debt Ratio topped out at 0.15 in Q4 2013 and bottomed at 0.15 in Q4 2013.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	1.41
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	0.11
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	0.05
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Neurogene	776.69 Mn	776.69 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2013	0.15